Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie
Research facility
Location:
Stuttgart
ISNI: 000000040561903X
ROR: https://ror.org/02pnjnj33
Show on Map:
Adverse drug reactions (ADR) and emergencies-the prevalence of suspected ADR in four emergency departments in Germany Unerwünschte Arzneimittelwirkungen (UAW) in der Krankenhausnotaufnahme: Prävalenz von UAW-Verdachtsfällen in vier Notaufnahmezentren in Deutschland (2018)
Schurig AM, Böhme M, Just KS, Scholl C, Dormann H, Plank-Kiegele B, Seufferlein T, et al.
Journal article
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin (2018)
Schaeffeler E, Büttner F, Reustle A, Klumpp V, Winter S, Rausch S, Fisel P, et al.
Journal article
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016)
Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemacon A, Droit A, et al.
Journal article
Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans. (1995)
Fromm M, Hofmann U, Griese U, Mikus G
Journal article, Original article